Research Article
Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece
Table 6
Chemotherapy regimens that were administered as second-line treatment.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
CAPOX, oxaliplatin/capecitabine; CAPOXIRI, oxaliplatin/irinotecan/capecitabine; FOLFIRI, irinotecan/leucovorin/5-fluorouracil; FOLFOX, oxaliplatin/leucovorin/5-fluorouracil; FOLFIRINOX, oxaliplatin/irinotecan/leucovorin/5-fluorouracil. |